-+ 0.00%
-+ 0.00%
-+ 0.00%

Faron Pharmaceuticals voting rights fall to 9.37% after bond amortisation with treasury shares

PUBT·08/04/2026 13:02:35
Listen to the news
Faron Pharmaceuticals voting rights fall to 9.37% after bond amortisation with treasury shares
  • Faron Pharmaceuticals disclosed its voting rights fell to 9.37%, or 21,342,679 shares, from 10.97% on Aug. 3, 2026.
  • The threshold change followed an event reshaping voting rights tied to amortisation of the First and Second Tranche Bonds using treasury shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Faron Pharmaceuticals Oyj published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein.